Clinical Trial Update: Feasibility and Safety of autoloGous UncondItioneD pEripheral Nerve Tissue Delivery to the Substantia Nigra (GUIDE) [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating the feasibility and safety of autologous unconditioned peripheral nerve tissue delivery to the substantia nigra for Parkinson's …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Autologous unconditioned peripheral nerve tissue delivery to the substantia nigra

Snippet

Sponsor: Craig van Horne, MD, PhD | Conditions: Parkinson's Disease | Phase 1 | Status: ACTIVE_NOT_RECRUITING